Cold, dry air is the ideal climate for viruses like the flu, phenomena and Respiratory Syncytial Virus (RSV), and these low ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

For a few years, the second seasonal COVID-19 spike has been accompanied by rising cases of seasonal flu and RSV in what ...

The NHS is urging eligible patients to protect themselves this winter by getting vaccinated against respiratory syncytial ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

The NSW government will spend $16m for a free vaccination scheme to combat respiratory syncytial virus in babies, starting ...

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

The holidays are fast approaching along with cooler weather and various respiratory illnesses. Here's when to get your ...

Johnson East took Bear in for his shot during his first pediatrician appointment. “He handled it very well,” she remembers. “We didn’t see any side effects with him. We were walked through the side ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...